Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Disability in Patients With Osteoarthritis
CompletedNot applicableNCT01137266
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine the effects of transcutaneous electrical nerve stimulation (TENS) on pain and mobility by comparing different stimulation sitesP: 1. the location with the lowest resistance 2. the location that causes an irradiation sensation 3. a random stimulation site (but within a 10x10cm area of the irradiation site). The effect is defined as the pain VAS baseline-measurement before treatment minus the pain VAS repeat-measurement after the given treatment
Study details
- Official title
- Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Disability in Patients With Osteoarthritis
- Conditions
- Interventions
- Sponsor
- Maxima Medical Center
- Collaborators
- Philips Electronics Nederland BV
- Start date
- 2008-07
- Primary completion
- 2010-09
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Netherlands
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * osteo-arthritis patients diagnosed by medical professional * at least 18 years old * VAS higher than 40mm, lower than 70mm (on a 100 mm VAS scale) at the moment of the investigation * pain symptoms duration longer than 3 months Exclusion Criteria: * unable to comprehend instructions * unable to co-operate * malignancy * recent bleeding tissue or haemorrhage in knee * epilepsy * advanced cardiovascular conditions, e.g. severe angina or cardiac arrhythmias * Pacemakers or cochlear implants * pregnant * sensory loss of the area to be treated * devitalised skin e.g. after recent radiotherapy; * local acute skin conditions e.g. eczema, dermatitis * doubtful diagnoses * global, multiple location pain (other than both knees) * people who undergo currently a TENS treatment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01137266